Deltombe O, Van Biesen W, Glorieux G, Massy Z, Dhondt A, Eloot S. Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis. Toxins (Basel). 2015;7(10):3933–46.

Article  CAS  PubMed  Google Scholar 

Zhao H, Chen L, Yang T, Feng YL, Vaziri ND, Liu BL, et al. Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma. J Transl Med. 2019;17(1):302.

Article  PubMed  PubMed Central  Google Scholar 

Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat Rev Cancer. 2013;13(12):827–41.

Article  CAS  PubMed  Google Scholar 

Gutierrez-Vazquez C, Quintana FJ. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity. 2018;48(1):19–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salminen A. Aryl hydrocarbon receptor (AhR) reveals evidence of antagonistic pleiotropy in the regulation of the aging process. Cell Mol Life Sci. 2022;79(9):489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sayed TS, Maayah ZH, Zeidan HA, Agouni A, Korashy HM. Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development. Cell Mol Biol Lett. 2022;27(1):103.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu JR, Miao H, Deng DQ, Vaziri ND, Li P, Zhao YY. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation. Cell Mol Life Sci. 2021;78(3):909–22.

Article  CAS  PubMed  Google Scholar 

Shinde R, Hezaveh K, Halaby MJ, Kloetgen A, Chakravarthy A, da Silva MT, et al. Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans. Nat Immunol. 2018;19(6):571–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ravid JD, Kamel MH, Chitalia VC. Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease. Nat Rev Nephrol. 2021;17(6):402–16.

Article  CAS  PubMed  Google Scholar 

Xu S, Zhang Y, Li Y, Xia X, Zhou J, Shi G. Production of L-tyrosine using tyrosine phenol-lyase by whole cell biotransformation approach. Enzyme Microb Technol. 2019;131: 109430.

Article  CAS  PubMed  Google Scholar 

Blakley ER. The catabolism of L-tyrosine by an Arthrobacter sp. Can J Microbiol. 1977;23(9):1128–39.

Article  CAS  PubMed  Google Scholar 

Powell JT, Morrison JF. The purification and properties of the aspartate aminotransferase and aromatic-amino-acid aminotransferase from Escherichia coli. Eur J Biochem. 1978;87(2):391–400.

Article  CAS  PubMed  Google Scholar 

Seah SY, Britton KL, Rice DW, Asano Y, Engel PC. Single amino acid substitution in Bacillus sphaericus phenylalanine dehydrogenase dramatically increases its discrimination between phenylalanine and tyrosine substrates. Biochemistry. 2002;41(38):11390–7.

Article  CAS  PubMed  Google Scholar 

Selmer T, Andrei PI. p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. Eur J Biochem. 2001;268(5):1363–72.

Article  CAS  PubMed  Google Scholar 

Brix LA, Barnett AC, Duggleby RG, Leggett B, McManus ME. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies. Biochemistry. 1999;38(32):10474–9.

Article  CAS  PubMed  Google Scholar 

Burchell B, Coughtrie MW. UDP-glucuronosyltransferases. Pharmacol Ther. 1989;43(2):261–89.

Article  CAS  PubMed  Google Scholar 

Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. p-Cresyl sulfate. Toxins (Basel). 2017;9(2):52.

Article  PubMed  Google Scholar 

Wyatt M, Greathouse KL. Targeting dietary and microbial tryptophan-indole metabolism as therapeutic approaches to colon cancer. Nutrients. 2021;13(4):1189.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: tryptophan’s metabolites in exercise, inflammation, and mental health. Science. 2017;357(6349).

Keskin DB, Marshall B, Munn D, Mellor AL, Gearhart DA. Decreased protein nitration in macrophages that overexpress indoleamine 2,3-dioxygenase. Cell Mol Biol Lett. 2007;12(1):82–102.

Article  CAS  PubMed  Google Scholar 

Sugiyama Y, Mori Y, Nara M, Kotani Y, Nagai E, Kawada H, et al. Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production. Gut Microbes. 2022;14(1):2128605.

Article  PubMed  PubMed Central  Google Scholar 

Schroeder JC, Dinatale BC, Murray IA, Flaveny CA, Liu Q, Laurenzana EM, et al. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry. 2010;49(2):393–400.

Article  CAS  PubMed  Google Scholar 

Diani-Moore S, Ma Y, Labitzke E, Tao H, David Warren J, Anderson J, et al. Discovery and biological characterization of 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole as an aryl hydrocarbon receptor activator generated by photoactivation of tryptophan by sunlight. Chem Biol Interact. 2011;193(2):119–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oberg M, Bergander L, Hakansson H, Rannug U, Rannug A. Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol Sci. 2005;85(2):935–43.

Article  PubMed  Google Scholar 

Centofanti F, Buono A, Verboni M, Tomino C, Lucarini S, Duranti A, et al. Synthetic methodologies and therapeutic potential of indole-3-carbinol (I3C) and its derivatives. Pharmaceuticals (Basel). 2023;16(2):240.

Article  CAS  PubMed  Google Scholar 

Zhen J, Zhou Z, He M, Han HX, Lv EH, Wen PB, et al. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front Endocrinol (Lausanne). 2023;14:1085041.

Article  PubMed  Google Scholar 

Wiedeman AM, Barr SI, Green TJ, Xu Z, Innis SM, Kitts DD. Dietary choline intake: current state of knowledge across the life cycle. Nutrients. 2018;10(10):1513.

Article  PubMed  PubMed Central  Google Scholar 

Koeth RA, Lam-Galvez BR, Kirsop J, Wang Z, Levison BS, Gu X, et al. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J Clin Invest. 2019;129(1):373–87.

Article  PubMed  Google Scholar 

Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, et al. gamma-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 2014;20(5):799–812.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho CE, Caudill MA. Trimethylamine-N-oxide: friend, foe, or simply caught in the cross-fire? Trends Endocrinol Metab. 2017;28(2):121–30.

Article  CAS  PubMed  Google Scholar 

Cho CE, Taesuwan S, Malysheva OV, Bender E, Tulchinsky NF, Yan J, et al. Trimethylamine-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res. 2017;61(1).

Bjorndal B, Ramsvik MS, Lindquist C, Nordrehaug JE, Bruheim I, Svardal A, et al. A phospholipid-protein complex from antarctic krill reduced plasma homocysteine levels and increased plasma trimethylamine-oxide (TMAO) and carnitine levels in male wistar rats. Mar Drugs. 2015;13(9):5706–21.

Article  PubMed  PubMed Central  Google Scholar 

Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63(5):1934–43.

Article  CAS  PubMed  Google Scholar 

Rosner MH, Reis T, Husain-Syed F, Vanholder R, Hutchison C, Stenvinkel P, et al. Classification of uremic toxins and their role in kidney failure. Clin J Am Soc Nephrol. 2021;16(12):1918–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update. Toxins (Basel). 2018;10(1):33.

Article  PubMed  Google Scholar 

Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, et al. IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor. Nat Immunol. 2021;22(3):358–69.

Article  CAS